<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Curated"><PMID Version="2">33845794</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Decreased blood CD4+ T lymphocyte helps predict cognitive impairment in patients with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>157</StartPage><MedlinePgn>157</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">157</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-021-02185-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">ALS patients have changed peripheral immunity. It is unknown whether peripheral immunity is related to cognitive dysfunction in ALS patients.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore the relationship between the peripheral blood lymphocyte subsets and the cognitive status in ALS patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Among 81 ALS patients, we compared the demographic, clinical, and peripheral levels of total T lymphocyte, CD4+ T lymphocyte, CD8+ T lymphocyte, B lymphocyte, and NK cell between those with cognitive impairment (ALS-ci) and those without (ALS-nci). The cognitive status was evaluated via the Chinese version of the Edinburgh cognitive and behavioral screen (ECAS). Significant predictors of cognitive impairment in univariate logistic regression analysis were further examined using multivariate logistic regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">39.5% of all ALS patients had cognitive impairment. The ALS-ci group had shorter education time, older age at both symptom onset and testing, longer disease duration, and lower levels of peripheral total, CD4+, and CD8+ T lymphocyte and B lymphocyte than the ALS-nci group. Frequency of behavioral impairment did not differ between the two groups. While parameters with significant differences identified by group comparison were also significant predictors of cognitive impairment in univariate logistic regression analysis except the level of B lymphocyte, only older age at testing, education time less than 9 years, and lower level of CD4+ T lymphocyte remained significant in multivariate logistic regression analysis. The predictive model combining these three parameters had an area under the receiver operating characteristic curve value of 0.842 with a sensitivity of 90.6% and a specificity of 67.3%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In Chinese ALS patients, blood CD4+ T lymphocyte might help evaluate cognitive impairment along with age and education level.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Avenue 1095, 430030, Wuhan, Hubei, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Dengji</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Avenue 1095, 430030, Wuhan, Hubei, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Zhenxiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Avenue 1095, 430030, Wuhan, Hubei, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Avenue 1095, 430030, Wuhan, Hubei, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zehui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Avenue 1095, 430030, Wuhan, Hubei, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Fengfei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Avenue 1095, 430030, Wuhan, Hubei, PR China. liumao1987@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Avenue 1095, 430030, Wuhan, Hubei, PR China. zhang_min_3464@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="Y">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004522" MajorTopicYN="N">Educational Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016131" MajorTopicYN="Y">Lymphocyte Subsets</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">ECAS</Keyword><Keyword MajorTopicYN="N">Peripheral blood lymphocyte subsets</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33845794</ArticleId><ArticleId IdType="pmc">PMC8039093</ArticleId><ArticleId IdType="doi">10.1186/s12883-021-02185-w</ArticleId><ArticleId IdType="pii">10.1186/s12883-021-02185-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gordon PH. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis. 2013;4(5):295&#x2013;310. doi: 10.14336/ad.2013.0400295.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/ad.2013.0400295</ArticleId><ArticleId IdType="pmc">PMC3794725</ArticleId><ArticleId IdType="pubmed">24124634</ArticleId></ArticleIdList></Reference><Reference><Citation>Silani V, Ludolph A, Fornai F. The emerging picture of ALS: a multisystem, not only a motor neuron disease. Arch Ital Biol. 2017;155(4):99&#x2013;109. doi: 10.12871/00039829201741.</Citation><ArticleIdList><ArticleId IdType="doi">10.12871/00039829201741</ArticleId><ArticleId IdType="pubmed">29405027</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman AB, Woolley-Levine S, Bradley WG, Miller RG. Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8(1):56&#x2013;61. doi: 10.1080/17482960601044106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960601044106</ArticleId><ArticleId IdType="pubmed">17364437</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy J, Henry R, Lomen-Hoerth C. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007;64(3):330&#x2013;334. doi: 10.1001/archneur.64.3.330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.3.330</ArticleId><ArticleId IdType="pubmed">17353375</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6(11):994&#x2013;1003. doi: 10.1016/s1474-4422(07)70265-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(07)70265-x</ArticleId><ArticleId IdType="pubmed">17945153</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3&#x2013;4):153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65(11):1774&#x2013;7. 10.1212/01.wnl.0000188759.87240.8b.</Citation><ArticleIdList><ArticleId IdType="pubmed">16344521</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Vignola A, Mastro E, Giudici AD, Iazzolino B, Calvo A, et al. Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol. 2010;17(10):1298&#x2013;303. 10.1111/j.1468-1331.2010.03016.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">20402747</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnini F, Rossi G, Lunetta C, Banfi P, Castelnuovo G, Corbo M, et al. Burden, depression, and anxiety in caregivers of people with amyotrophic lateral sclerosis. Psychol Health Med. 2010;15(6):685&#x2013;93. 10.1080/13548506.2010.507773.</Citation><ArticleIdList><ArticleId IdType="pubmed">21154021</ArticleId></ArticleIdList></Reference><Reference><Citation>Khin Khin E, Minor D, Holloway A, Pelleg A. Decisional capacity in amyotrophic lateral sclerosis. J Am Acad Psychiatry Law. 2015;43(2):210&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">26071511</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12(4):368&#x2013;380. doi: 10.1016/s1474-4422(13)70026-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(13)70026-7</ArticleId><ArticleId IdType="pubmed">23518330</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye S, Ji Y, Li C, He J, Liu X, Fan D. The Edinburgh cognitive and behavioural ALS screen in a Chinese amyotrophic lateral sclerosis population. PLoS One. 2016;11 5:e0155496; doi: 10.1371/journal.pone.0155496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4873026</ArticleId><ArticleId IdType="pubmed">27195772</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotrophic Lateral Scler Frontotemporal Degener. 2014;15(1&#x2013;2):9&#x2013;14. doi: 10.3109/21678421.2013.805784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.805784</ArticleId><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh cognitive and Behavioural amyotrophic lateral sclerosis screen (ECAS): a cognitive tool for motor disorders. Amyotrophic Lateral Scler Frontotemporal Degener. 2015;16(3&#x2013;4):172&#x2013;9. 10.3109/21678421.2015.1030430.</Citation><ArticleIdList><ArticleId IdType="pubmed">25967542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Burkhardt C, Abdulla S, B&#xf6;hm S, Kollewe K, Uttner I, et al. The Edinburgh cognitive and Behavioural amyotrophic lateral sclerosis screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotrophic Lateral Scler Frontotemporal Degener. 2015;16(1&#x2013;2):16&#x2013;23. 10.3109/21678421.2014.959451.</Citation><ArticleIdList><ArticleId IdType="pubmed">25292386</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, et al. The validation of the Italian Edinburgh cognitive and Behavioural ALS screen (ECAS). Amyotrophic Lateral Scler Frontotemporal Degener. 2016;17(7&#x2013;8):489&#x2013;98. 10.1080/21678421.2016.1183679.</Citation><ArticleIdList><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, Trojano L, Trojsi F, Greco R, Santoro M, Basile G, et al. Edinburgh cognitive and behavioural ALS screen (ECAS)-Italian version: regression based norms and equivalent scores. Neurol Sci. 2017;38(6):1059&#x2013;68. 10.1007/s10072-017-2919-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">28332040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora JS, Salas T, Fern&#xe1;ndez MC, Rodr&#xed;guez-Castillo V, Mar&#xed;n S, Chaverri D, et al. Spanish adaptation of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS). Amyotrophic Lateral Scler Frontotemporal Degener. 2018;19(1&#x2013;2):74&#x2013;9. 10.1080/21678421.2017.1406952.</Citation><ArticleIdList><ArticleId IdType="pubmed">29212378</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson MP, Staff NP. Bornschlegl S, Butler GW, Maas ML, Kazamel M, et al. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS One. 2017;12(7):e0182002. doi: 10.1371/journal.pone.0182002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182002</ArticleId><ArticleId IdType="pmc">PMC5526569</ArticleId><ArticleId IdType="pubmed">28742871</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani S, Garbelli S, Pasini A, Alimonti D, Perotti C, Melazzini M, et al. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J Neuroimmunol. 2009;210(1&#x2013;2):73&#x2013;9. 10.1016/j.jneuroim.2009.02.012.</Citation><ArticleIdList><ArticleId IdType="pubmed">19307024</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 2017;74(12):1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M, Evangelopoulos E, Sereti E, Zouvelou V, Marmara S, Alexakis T, et al. Alterations of T cell subsets in ALS: a systemic immune activation? Acta Neurol Scand. 2012;125(4):260&#x2013;4. 10.1111/j.1600-0404.2011.01528.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">21651502</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Hadlock K, et al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2005;159(1&#x2013;2):215&#x2013;24. 10.1016/j.jneuroim.2004.10.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">15652422</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Feng W, Huang R, Guo X, Chen Y, Zheng Z, et al. Evidence for peripheral immune activation in amyotrophic lateral sclerosis. J Neurol Sci. 2014;347(1&#x2013;2):90&#x2013;5. 10.1016/j.jns.2014.09.025.</Citation><ArticleIdList><ArticleId IdType="pubmed">25312013</ArticleId></ArticleIdList></Reference><Reference><Citation>Provinciali L, Laurenzi MA, Vesprini L, Giovagnoli AR, Bartocci C, Montroni M, et al. Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol Scand. 1988;78(6):449&#x2013;54. 10.1111/j.1600-0404.1988.tb03686.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">3265563</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse M, Michler E, von Hoff F, Dobrowolny H, Hartig R, Frodl T, et al. Alterations in the peripheral immune system in dementia. J Alzheimers Dis. 2017;58(4):1303&#x2013;13. 10.3233/jad-161304.</Citation><ArticleIdList><ArticleId IdType="pubmed">28582858</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonotis K, Krikki E, Holeva V, Aggouridaki C, Costa V, Baloyannis S. Systemic immune aberrations in Alzheimer's disease patients. J Neuroimmunol. 2008;193(1&#x2013;2):183&#x2013;187. doi: 10.1016/j.jneuroim.2007.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2007.10.020</ArticleId><ArticleId IdType="pubmed">18037502</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu ZX, Song WN, Lu XD, Zhou ML, Shao JH. Peripheral T lymphocyte immunity and l-dopamine in patients with Parkinson's disease. J Biol Regul Homeost Agents. 2018;32(3):687&#x2013;691.</Citation><ArticleIdList><ArticleId IdType="pubmed">29921400</ArticleId></ArticleIdList></Reference><Reference><Citation>Magistrelli L, Storelli E, Rasini E, Contaldi E, Comi C, Cosentino M, et al. Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease. Brain Behav Immun. 2020;89:668&#x2013;74. 10.1016/j.bbi.2020.07.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">32688028</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J Neurol Sci. 1999;169(1&#x2013;2):13&#x2013;21. doi: 10.1016/s0022-510x(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugger F, Erro R, Balint B, K&#xe4;gi G, Barone P, Bhatia KP. Why is there motor deterioration in Parkinson's disease during systemic infections-a hypothetical view. NPJ Parkinsons Dis. 2015;1(1):15014. doi: 10.1038/npjparkd.2015.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npjparkd.2015.14</ArticleId><ArticleId IdType="pmc">PMC5516617</ArticleId><ArticleId IdType="pubmed">28725683</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonar SA, Lal G. Blood-brain barrier and its function during inflammation and autoimmunity. J Leukoc Biol. 2018;103(5):839&#x2013;853. doi: 10.1002/jlb.1ru1117-428r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.1ru1117-428r</ArticleId><ArticleId IdType="pubmed">29431873</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann H, Wekerle H. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol. 1998;57(1):1&#x2013;9. doi: 10.1097/00005072-199801000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199801000-00001</ArticleId><ArticleId IdType="pubmed">9600191</ArticleId></ArticleIdList></Reference><Reference><Citation>Brynskikh A, Warren T, Zhu J, Kipnis J. Adaptive immunity affects learning behavior in mice. Brain Behav Immun. 2008;22(6):861&#x2013;869. doi: 10.1016/j.bbi.2007.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2007.12.008</ArticleId><ArticleId IdType="pubmed">18249087</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipnis J, Cohen H, Cardon M, Ziv Y, Schwartz M. T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci U S A. 2004;101(21):8180&#x2013;8185. doi: 10.1073/pnas.0402268101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402268101</ArticleId><ArticleId IdType="pmc">PMC419577</ArticleId><ArticleId IdType="pubmed">15141078</ArticleId></ArticleIdList></Reference><Reference><Citation>Radjavi A, Smirnov I, Kipnis J. Brain antigen-reactive CD4+ T cells are sufficient to support learning behavior in mice with limited T cell repertoire. Brain Behav Immun. 2014;35:58&#x2013;63. doi: 10.1016/j.bbi.2013.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2013.08.013</ArticleId><ArticleId IdType="pmc">PMC3858511</ArticleId><ArticleId IdType="pubmed">24012647</ArticleId></ArticleIdList></Reference><Reference><Citation>Filiano AJ, Gadani SP, Kipnis J. How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci. 2017;18(6):375&#x2013;384. doi: 10.1038/nrn.2017.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.39</ArticleId><ArticleId IdType="pmc">PMC5823005</ArticleId><ArticleId IdType="pubmed">28446786</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Sanberg PR. Blood-CNS barrier impairment in ALS patients versus an animal model. Front Cell Neurosci. 2014;8:21. doi: 10.3389/fncel.2014.00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00021</ArticleId><ArticleId IdType="pmc">PMC3910123</ArticleId><ArticleId IdType="pubmed">24550780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicaise C, Mitrecic D, Demetter P, De Decker R, Authelet M, Boom A, et al. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 2009;1301:152&#x2013;162. doi: 10.1016/j.brainres.2009.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.09.018</ArticleId><ArticleId IdType="pubmed">19748495</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 2007;1157:126&#x2013;137. doi: 10.1016/j.brainres.2007.04.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.04.044</ArticleId><ArticleId IdType="pubmed">17512910</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnenfeld H, Kascsak RJ, Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J Neuroimmunol. 1984;6(1):51&#x2013;57. doi: 10.1016/0165-5728(84)90042-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-5728(84)90042-0</ArticleId><ArticleId IdType="pubmed">6368581</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, Haller E, Frisina-Deyo A, Mirtyl S, et al. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012;1469:114&#x2013;128. doi: 10.1016/j.brainres.2012.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.05.056</ArticleId><ArticleId IdType="pubmed">22750125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140(3):691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26(4):459&#x2013;470. doi: 10.1002/mus.10191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10191</ArticleId><ArticleId IdType="pubmed">12362410</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11(3):232&#x2013;40. 10.1016/S1474-4422(12)70014-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao B, Tang B, Liu X, Yan X, Zhou L, Yang Y, et al. Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China. Neurobiol Aging. 2014;35(4):936 e19&#x2013;936 e22. doi: 10.1016/j.neurobiolaging.2013.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.10.001</ArticleId><ArticleId IdType="pubmed">24269022</ArticleId></ArticleIdList></Reference><Reference><Citation>Carelli L, Solca F, Faini A, Madotto F, Lafronza A, Monti A, et al. The complex interplay between depression/anxiety and executive functioning: insights from the ECAS in a large ALS population. Front Psychol. 2018;9:450. 10.3389/fpsyg.2018.00450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5895754</ArticleId><ArticleId IdType="pubmed">29674987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SM, Lee KM, Hong YH, Park KS, Yang JH, Nam HW, et al. Relation between cognitive dysfunction and reduced vital capacity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78(12):1387&#x2013;9. 10.1136/jnnp.2006.111195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2095584</ArticleId><ArticleId IdType="pubmed">17557798</ArticleId></ArticleIdList></Reference><Reference><Citation>Llewellyn D, Langa K, Friedland R, Lang I. Serum albumin concentration and cognitive impairment. Curr Alzheimer Res. 2010;7(1):91&#x2013;96. doi: 10.2174/156720510790274392.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720510790274392</ArticleId><ArticleId IdType="pmc">PMC2886725</ArticleId><ArticleId IdType="pubmed">20205675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng TP, Feng L, Niti M, Yap KB. Albumin, haemoglobin, BMI and cognitive performance in older adults. Age Ageing. 2008;37(4):423&#x2013;429. doi: 10.1093/ageing/afn102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afn102</ArticleId><ArticleId IdType="pubmed">18495687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Highton-Williamson E, Caga J, Thornton N, Ramsey E, Zoing M, et al. Lipid metabolism and survival across the Frontotemporal dementia-amyotrophic lateral sclerosis Spectrum: relationships to eating behavior and cognition. J Alzheimers Dis. 2018;61(2):773&#x2013;83. 10.3233/jad-170660.</Citation><ArticleIdList><ArticleId IdType="pubmed">29254092</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>